Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pamine
Drug ID BADD_D01663
Description A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
Indications and Usage Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.
Marketing Status Not Available
ATC Code A03BB03; S01FA03
DrugBank ID DB00462
KEGG ID D01976
MeSH ID D019832
PubChem ID 4120
TTD Drug ID Not Available
NDC Product Code 51927-0047; 43063-740; 51991-191; 55742-014; 43063-741; 51991-192; 76385-101; 51886-0301; 76385-100
Synonyms N-Methylscopolamine | N Methylscopolamine | Methscopolamine | N-Methylscine Methylsulfate | Methylsulfate, N-Methylscine | N Methylscine Methylsulfate | N-Methylscopolamine Bromide | Bromide, N-Methylscopolamine | N Methylscopolamine Bromide | Hyoscine Methobromide | Methobromide, Hyoscine | Scopolamine Methylbromide | Methylbromide, Scopolamine | N-Methylscopolamine Iodide | Iodide, N-Methylscopolamine | N Methylscopolamine Iodide | Hyoscine Methiodide | Methiodide, Hyoscine | N-Methylscopolamine Methylsulfate | Methylsulfate, N-Methylscopolamine | N Methylscopolamine Methylsulfate | Methylscopolammonium Methylsulfate | Methylsulfate, Methylscopolammonium | N-Methylscopolamine Nitrate | N Methylscopolamine Nitrate | Nitrate, N-Methylscopolamine | Methylscopolamine Nitrate | Nitrate, Methylscopolamine | Skopyl | Ulix | DD-234 | DD 234 | DD234 | N-Methylscopolamine Methylchloride | Methylchloride, N-Methylscopolamine | N Methylscopolamine Methylchloride
Chemical Information
Molecular Formula C18H24NO4+
CAS Registry Number 155-41-9
SMILES C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Accommodation disorder06.02.04.001--Not Available
Ageusia17.02.07.001; 07.14.03.003--Not Available
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Asthenia08.01.01.001--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Cycloplegia17.17.02.003; 06.05.03.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Feeling abnormal08.01.09.014--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypohidrosis23.02.03.005; 08.01.03.029--
Insomnia19.02.01.002; 17.15.03.002--
Mydriasis06.05.03.004; 17.02.11.003--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Palpitations02.01.02.003--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Urinary hesitation20.02.02.009--Not Available
Urticaria10.01.06.001; 23.04.02.001--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Erectile dysfunction21.03.01.007; 19.08.04.001--
The 1th Page    1    Total 1 Pages